sibutramine has been researched along with Complication, Postoperative in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "We, therefore, conducted a study in which 20 bariatric patients received 15 mg of the weight loss medication sibutramine prior to laparoscopic Roux-en-Y gastric bypass (RYGBP) while patients in the control group did not." | 3.75 | Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time. ( Aberle, J; Beil, FU; Busch, P; Dannheim, V; Freier, A; Mann, O; Mommsen, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aberle, J | 1 |
| Freier, A | 1 |
| Busch, P | 1 |
| Mommsen, N | 1 |
| Beil, FU | 1 |
| Dannheim, V | 1 |
| Mann, O | 1 |
1 other study available for sibutramine and Complication, Postoperative
| Article | Year |
|---|---|
Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time.
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Gastric Bypass; Humans; Liver; Male; Obesity, Mor | 2009 |